Display Settings:

Format

Send to:

Choose Destination
    Neurology. 2001 Mar 27;56(6):794-6.

    Modafinil for excessive daytime sleepiness in myotonic dystrophy.

    Source

    Department of Neurology, Carl Gustav Carus University Hospital, University of Technology, Dresden, Germany. damian@rcs.urz.tu-dresden.de

    Abstract

    The authors conducted an open-label trial of modafinil for excessive daytime sleepiness in myotonic dystrophy. Eleven patients were evaluated: two were not treated because of obstructive sleep apnea, and nine received 200 to 400 mg modafinil/day for an average of 16.4 weeks. There were no major side effects. Average sleep latency as measured by the Multiple Sleep Latency Test increased from 7.3 to 22.7 minutes ( p = 0.00013), and average Epworth Sleepiness Scale score decreased from 13.25 to 7.75 (p = 0.01028). Modafinil shows evidence of effectiveness for excessive daytime somnolence in myotonic dystrophy and should be investigated further.

    PMID:
    11274321
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk